Tuesday's Health Winners & Losers
Among the winners in the health sector Tuesday was Angiotech Pharmaceuticals (ANPI), shares of which rose about 12%. The Vancouver-based drug and medical-device company, which last week halted patient enrollment in a study of its Vascular Wrap for artery disease due to safety issues, said Tuesday it is exploring "alternatives for the future funding and development" of the product, including potential partnerships. The company posted an adjusted net loss from continuing operations of $3.9 million, or 5 cents a share, in the first quarter. The stock, which took a hard hit last week, climbed 34 cents, or 12.8%, to $2.99.Another win came courtesy of Hanger Orthopedic Group (HGR), shares of which climbed more than 8% on quarterly results and forward guidance. The Bethesda-based company, which distributes orthotic and prosthetic devices and operates related care centers, posted first-quarter net income of $3.6 million, or 12 cents a share, double the $1.8 million, or 6 cents a share, it posted a year ago. Hanger increased its full-year EPS guidance by a nickel to a range of 75 cents to 77 cents in light of more favorable interest rates. The stock traded up 8.7% to $11.58.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV